consensus guidelines
Recently Published Documents


TOTAL DOCUMENTS

1303
(FIVE YEARS 372)

H-INDEX

119
(FIVE YEARS 16)

Author(s):  
David de Gonzalo-Calvo ◽  
Monica Marchese ◽  
Jan Hellemans ◽  
Fay Betsou ◽  
Nanna Lond Skov Frisk ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
pp. 111
Author(s):  
Arno Vanstapel ◽  
Stijn E. Verleden ◽  
Eric K. Verbeken ◽  
Peter Braubach ◽  
Tinne Goos ◽  
...  

Bronchiolitis obliterans syndrome (BOS) is considered an airway-centered disease, with bronchiolitis obliterans (BO) as pathologic hallmark. However, the histologic spectrum of pure clinical BOS remains poorly characterized. We provide the first in-depth histopathologic description of well-characterized BOS patients and patients without chronic lung allograft dysfunction (CLAD), defined according to the recent consensus guidelines. Explant lung tissue from 52 clinically-defined BOS and 26 non-CLAD patients (collected 1993–2018) was analyzed for histologic parameters, including but not limited to airway lesions, vasculopathy and fibrosis. In BOS, BO lesions were evident in 38 (73%) patients and varied from concentric sub-epithelial fibrotic BO to inflammatory BO, while 10/14 patients without BO displayed ‘vanishing airways’, defined by a discordance between arteries and airways. Chronic vascular abnormalities were detected in 22 (42%) patients. Ashcroft fibrosis scores revealed a median of 43% (IQR: 23–69) of normal lung parenchyma per patient; 26% (IQR: 18–37) of minimal alveolar fibrous thickening; and 11% (IQR: 4–18) of moderate alveolar thickening without architectural damage. Patchy areas of definite fibrotic damage to the lung structure (i.e., Ashcroft score ≥ 5) were present in 28 (54%) patients. Fibrosis was classified as bronchocentric (n = 21/28, 75%), paraseptal (n = 17/28, 61%) and subpleural (n = 15/28, 54%). In non-CLAD patients, BO lesions were absent, chronic vascular abnormalities present in 1 (4%) patient and mean Ashcroft scores were significantly lower compared to BOS (p = 0.0038) with 78% (IQR:64–88) normally preserved lung parenchyma. BOS explant lungs revealed evidence of various histopathologic findings, including vasculopathy and fibrotic changes, which may contribute to the pathophysiology of BOS.


Cancers ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 34
Author(s):  
Enrico Vizza ◽  
Valentina Bruno ◽  
Giuseppe Cutillo ◽  
Emanuela Mancini ◽  
Isabella Sperduti ◽  
...  

Objective: The aim of our study was to investigate the role of the excised vaginal cuff length as a prognostic factor in terms of DFS and recurrence rate/site, in low-risk endometrial cancer (EC) patients. Moreover, we correlated the recurrence with the expression of L1CAM. Material and Methods: From March 2001 to November 2016, a retrospective data collection was conducted of women undergoing surgical treatment for low-risk EC according to ESMO-ESGO-ESTRO consensus guidelines. Patients were divided into three groups according to their vaginal cuff length: V0 without vaginal cuff, V1 with a vaginal cuff shorter than 1.5 cm and V2 with a vaginal cuff longer than or equal to 1.5 cm. Results: 344 patients were included in the study: 100 in the V0 group, 179 in the V1 group and 65 in the V2 group. The total recurrence rate was 6.1%: the number of patients with recurrence was 8 (8%), 10 (5.6%) and 3 (4.6%), in the V0, V1 and V2 group, respectively. No statistically significant difference was found in the recurrence rate among the three groups. Although the DFS was higher in the V2 group, the result was not significant. L1CAM was positive in 71.4% of recurrences and in 82% of the distant recurrences. Conclusions: The rate of recurrence in patients with EC at low risk of recurrence does not decrease as the length of the vaginal cuff removed increases. Furthermore, the size of the removed vaginal cuff does not affect either the site of recurrence or the likelihood of survival.


2021 ◽  
Vol 4 (18) ◽  
pp. 01-03
Author(s):  
Ujjwal K. Chowdhury ◽  
Niwin George ◽  
Lakshmi Kumari Sankhyan ◽  
Shikha Goja ◽  
Sumanth Raghuprakash ◽  
...  

Current consensus guidelines of the AHA and ESC, uniformly recommend either type of prosthetic valve for patients aged 60 to 70 years and mechanical prosthesis for patients aged less than 60 years


2021 ◽  
Vol 149 (1) ◽  
pp. 212-224
Author(s):  
Devin Coon ◽  
Jens Berli ◽  
Norah Oles ◽  
Sol Mundinger ◽  
Kate Thomas ◽  
...  

2021 ◽  
pp. 2100047
Author(s):  
Amel Karaa ◽  
Laura E. MacMullen ◽  
John C. Campbell ◽  
John Christodoulou ◽  
Bruce H. Cohen ◽  
...  

2021 ◽  
Author(s):  
Elisa Mercanzin ◽  
Pietro Andrea Bonaffini ◽  
Antonino Barletta ◽  
Francesco Stanco ◽  
Clarissa Valle ◽  
...  

Lung pneumatoceles represent a potential life-threatening complication of pneumonia in infants, especially when they do not spontaneously reabsorb. In this category of patients, scientific literature lacks and no consensus guidelines for management have been proposed. Imaging plays a key role in the diagnosis, characterization, and follow-up of pneumatoceles. Image-guided percutaneous drainage can be considered a safe and effective treatment in children, although it is not widely recognized in newborns and infants. The aim of this case series review is to describe the main CT features of complicated or persistent pneumatoceles in infants and to highlight the potential role of image-guided percutaneous drainage as an effective approach for their treatment. Successful management of four infants affected by pneumonia-related pneumatoceles with percutaneous drainage is presented.


Sign in / Sign up

Export Citation Format

Share Document